iiinova — where your digital self keeps evolving

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 09/06/2026

Find us Friday, June 12 starting at 6:45 AM CT at the Sheraton Chicago Ballroom in Sections VIII-X; Fourth Floor during #NLASessions for this #CE symposium! More info: ow.ly/sOxL50YRGQa @nationallipid.bsky.social @erinmichos.bsky.social

011

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 06/06/2026

This interactive program is designed for physicians, nurses and pharmacists involved in the management of patients with dyslipidemia. Register now to attend at #NLASessions: ow.ly/sOxL50YRGQa @nationallipid.bsky.social @erinmichos.bsky.social

011

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 18/05/2026

Join us at #NLASessions in Chicago. You will explore the latest evidence on CETP inhibition as an emerging treatment approach for patients with dyslipidemia. Register today to join in person >> ow.ly/sOxL50YRGQa @nationallipid.bsky.social @erinmichos.bsky.social

021

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 10/05/2026

Step into the CME Situation Room at #NLASessions on 6/12! Registration is now open to attend in Chicago >> ow.ly/sOxL50YRGQa @nationallipid.bsky.social @erinmichos.bsky.social

021

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 05/05/2026

Attending #NLASessions in Chicago? Join us Friday, 6/12 for this #CE symposium: "CME Situation Room: Exploring the Cardiovascular and Neurocognitive Implications of CETP Inhibition" >> ow.ly/sOxL50YRGQa @nationallipid.bsky.social @erinmichos.bsky.social

011

Reposted by Erin Michos, MD

American Journal of Preventive Cardiology @ajpcardio.bsky.social · 14/02/2026

Reproductive risk factors & CV-kidney-metabolic syndrome in young women 🧬 New study highlights links between reproductive health factors and prevalence of cardiovascular-kidney-metabolic syndrome among young women. 👉 ow.ly/TBJg50YfpgZ #CardioRenalMetabolic

032

Erin Michos, MD @erinmichos.bsky.social · 05/01/2026

My quote by the @washingtonpost.com . Lp(a) is actionable now. Get tested! Know your number. #lipids #LPa

162

Reposted by Erin Michos, MD

Gary Singer @garysinger.bsky.social · 30/12/2025

Important article demonstrating cardiorenal collaboration @erinmichos.bsky.social and David Cherney @glaucomflecken.bsky.social who says cardiology and nephrology can’t work together?

273

Reposted by Erin Michos, MD

CardioOB @cardioob.bsky.social · 28/11/2025

🚀 Issue #2 90-Second Cardio-OB Journal Scan with @cardioobdoc.bsky.social Association between HDP & Premature CVD 🗞️ Nov 28, 2025 @ahajournals.bsky.social 🔗 www.ahajournals.org/doi/10.1161/... #ACCRepOB #ACCCardioOB #CardioObstetrics #CardioSky @erinmichos.bsky.social @shantelleb.bsky.social

055

Reposted by Erin Michos, MD

American Society for Preventive Cardiology @aspcardio.bsky.social · 04/12/2025

Grateful to @erinmichos.bsky.social & Dr. Wong for their dedication as Co-EICs of AJPC. Their final Editors’ Page reflects their impact on advancing cardiovascular science & ASPC’s mission! 🫀📚 Read: www.sciencedirect.com/science/arti... #PreventiveCardiology #HeartHealth #ASPC #cardiosky #medsky

041

Reposted by Erin Michos, MD

Roger Blumenthal @rblument1.bsky.social · 08/11/2025

Excellent presentation by Professor Erin Michos @erinmichos.bsky.social at #AHA25

151

Erin Michos, MD @erinmichos.bsky.social · 06/11/2025

Congratulations to our @hopkinsheart.bsky.social research fellow Dr @zaibhussain10.bsky.social on being a #QCOR Early Career Finalist at #AHA2025 ! 👏👏Check out her presentation Friday with simultaneous publication in Circ Outcomes on motivational themes for CV trial enrollment.

021

Reposted by Erin Michos, MD

allisonghaysmd.bsky.social @allisonghaysmd.bsky.social · 06/11/2025

🚨 Don’t miss the Early Career Investigators Session #AHA2025! Groundbreaking @hopkinsheart.bsky.social research on maternal mortality and CVD risk to be featured w/ simultaneous pub in Circulation. Congrats to coauthors and Hopkins team lead by Anum Minhas and Theresa Boyer @erinmichos.bsky.social

022

Erin Michos, MD @erinmichos.bsky.social · 06/11/2025

FINE-ONE was just presented at @asnkidney.bsky.social at #KidneyWk. #Finerenone significantly reduced #UACR by 25% at 6 months in patients with #T1D & #CKD - an understudied population with high unmet need.

130

Erin Michos, MD @erinmichos.bsky.social · 02/11/2025

Pleased to take part in this podcast about "Diagnostic Strategies for the Timely Detection of Familial Chylomicronemia Syndrome" with Dr Archna Bajaj. #FCS #lipids Sponsored by @vindicomeded.bsky.social & @gohealio.bsky.social www.healio.com/cme/mededtal...

healio.com

Diagnostic Strategies for the Timely Detection of FCS With Drs. Archna Bajaj and Erin Michos

010

Reposted by Erin Michos, MD

allisonghaysmd.bsky.social @allisonghaysmd.bsky.social · 07/09/2025

Excellent session on women’s heart health across the lifespan and role of Echo at #ASE2025 Featuring @erinmichos.bsky.social (women’s health leader @HopkinsHeart) @anabarac (pioneer in cardio-oncology), masterfully chaired by @sharonmulvagh expert in Echo and women’s CV health

132

Erin Michos, MD @erinmichos.bsky.social · 02/09/2025

CAC score 14 is the 84th %tile for 55yo woman! Calcified plaque is late stage plaque, she likely has non calcified plaque as well (not captured by CAC) amenable to regression if treated now. Given young age, has lot of life yrs at risk. Would treat with statin, aim for LDLC<70 & apoB<70. Check Lp(a)

020

Reposted by Erin Michos, MD

American Journal of Preventive Cardiology @ajpcardio.bsky.social · 11/08/2025

New study alert: Women with established coronary artery disease are less likely than men to receive guideline-based statin therapy—and face higher rates of recurrent cardiovascular events. Ensuring equal treatment equity could save more lives. Read more: www.sciencedirect.com/science/arti...

176

Reposted by Erin Michos, MD

Seme Burka @semeburka.bsky.social · 16/07/2025

For patients who can’t tolerate statins, or need more LDL-C lowering despite high-intensity therapy, bempedoic acid is a proven option that’s often overlooked. @erinmichos.bsky.social @ciccaronecenter.bsky.social Quick read our case 🔗 @accintouch.bsky.social learn.acc.org/Page/Bempedo...

065

Reposted by Erin Michos, MD

American Journal of Preventive Cardiology @ajpcardio.bsky.social · 17/07/2025

📢 New in AJPC: Study explores how gender and menopause status impact BP reduction in a mobile health self-management program for hypertension. @drmarthagulati.bsky.social @erinmichos.bsky.social 📱💡 Personalized care matters. ow.ly/H8ob50WrnQk #Hypertension #Cardiology #mHealth #AJPC

155

Reposted by Erin Michos, MD

American Society for Preventive Cardiology @aspcardio.bsky.social · 19/06/2025

We’re proud to celebrate @ajpcardio.bsky.social — official journal of the ASPC — on its 2024 impact factor of 5.9 & ranking 34 of 230 journals in Cardiac & Cardiovascular Systems! Kudos Dr. Nathan Wong, @erinmichos.bsky.social, & the AJPC community for advancing the field of preventive cardiology.

053

Reposted by Erin Michos, MD

Patricia George MD @patriciageorge5280.bsky.social · 12/06/2025

Having a great time and learning a ton at the @nationaljewish.org CV Symposium: Improving Cardiovascular Outcomes: The Next Era of Prevention. AND I got to see Dr. @erinmichos.bsky.social and ask her all my pressing cardiology questions. 🫀❤️👊

032

Reposted by Erin Michos, MD

Henry Han @hancardiomd.bsky.social · 12/06/2025

The impact of federal actions on academic medicine and the U.S. health care system www.aamc.org/about-us/aam... @cardioobdoc.bsky.social @arghavansallesmd.medsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social

034

Reposted by Erin Michos, MD

Fipco @fipco.bsky.social · 11/06/2025

Systemic review of discordance studies by Daniel Sehayek, et al. finds apoB generally outperforms LDL-C and non-HDL-C. (prior post of recent study adds to this evidence) #cardiosky www.lipidjournal.com/article/S193...

012

Reposted by Erin Michos, MD

American Journal of Preventive Cardiology @ajpcardio.bsky.social · 10/06/2025

June 2025 #AJPC Editors’ Message @erinmichos.bsky.social & Dr. Nathan Wong! Dive into cutting-edge articles on AI, psychosocial stress, obesity, chylomicronemia, and more in #CVDPrevention. Plus, a preview of #ASPC2025! www.sciencedirect.com/science/arti... #CardioSky @aspcardio.bsky.social

024

Reposted by Erin Michos, MD

HCPLive @hcplivenews.bsky.social · 07/06/2025

New at #HiD25: @erinmichos.bsky.social, director of women's cardiovascular health at Johns Hopkins University, met with us to discuss her presentation on postmenopausal hormone imbalance, obesity, and cardiovascular disease risk in women. Watch the interview here: www.hcplive.com/view/post-me...

021

Reposted by Erin Michos, MD

Johns Hopkins Cardiology @hopkinsheart.bsky.social · 01/04/2025

A huge congratulations to our Cardiology Fellowship APD, Dr. Anum Minhas, who was awarded the Young Author Achievement Award for @jaccjournals.bsky.social JACC Advances 💖

074

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 22/05/2025

🍳 FREE CME + breakfast + the latest breakthroughs in #ASCVD treatment Fri, May 30 | 7:15–8:45 AM at JW Marriott Miami Turnberry Resort and Spa #NLASessions 🔗 vindicoce.com/NLA @nationallipid.bsky.social @erinmichos.bsky.social @foundationofnla.bsky.social @lipidjournal.bsky.social

CE Breakfast Symposium during #NLASessions
Lowering LDL-C: The Role of Emerging CETP Inhibitors in Reducing CV Risk
Friday, May 30 at 7:15 AM

031

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 19/05/2025

Don’t miss the CETP comeback story—plus RAPID-FIRE ROUNDTABLE—at our CE breakfast on May 30 during #NLASessions Register here >> vindicoce.com/NLA @erinmichos.bsky.social @nationallipid.bsky.social @lipidjournal.bsky.social @foundationofnla.bsky.social

032

Erin Michos, MD @erinmichos.bsky.social · 18/05/2025

Pleased to be a co-author of this study and part of TANDEM steering committee. Given the critical importance of reducing LDL Cholesterol for preventing atherosclerotic cardiovascular disease, more options to lower LDL-C is a good thing!

060

Erin Michos, MD @erinmichos.bsky.social · 13/05/2025

Join me in Nashville Sept 5-7 for the American Society of Echocardiography @ase360.bsky.social Scientific Sessions and 50th year Anniversary! Join us for late breaking innovations & updates in cardiovascular ultrasound. #echofirst #ASE2025 #EchoSky

194

Reposted by Erin Michos, MD

Sharonne N. Hayes MD @sharonnehayes.bsky.social · 09/05/2025

Just finished up a great 2 days of learning & developing solutions for better heart health for women at Hello Heart’s 2nd annual conference. Rock star faculty & engaged participants. @erinmichos.bsky.social @jaynemorgan.bsky.social @womenheart.bsky.social

274

Erin Michos, MD @erinmichos.bsky.social · 08/05/2025

Exciting news for #liver health! The #GLP1RA #semaglutide significantly improved #MASH & fibrosis.

081

Reposted by Erin Michos, MD

NEJM.org @nejm.org · 07/05/2025

In a randomized trial of patients at high cardiovascular risk, the cholesteryl ester transfer protein inhibitor obicetrapib reduced low-density lipoprotein cholesterol levels by 29.9% at 84 days. Full BROADWAY trial results: nej.md/4lKsmMK @eassociety.bsky.social | #EASCongress2025

nej.md

Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk | NEJM

Obicetrapib is a highly selective cholesteryl ester transfer protein inhibitor that reduces low-density lipoprotein (LDL) cholesterol levels. The efficacy and safety of obicetrapib have not been fu...

1196

Erin Michos, MD @erinmichos.bsky.social · 08/05/2025

Pleased to share our results from the TANDEM Trial published in @thelancet.bsky.social today and presented at EAS: Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction: a phase 3, randomised, double-blind, placebo-controlled trial www.thelancet.com/journals/lan...

2116

Reposted by Erin Michos, MD

Vindico Medical Education @vindicomeded.bsky.social · 07/05/2025

Excited to be a part of #NLASessions! We're bringing an exciting #CE breakfast symposium on CETP inhibitors on Fri 5/30. Register here: vindicoce.com/NLA #ASCVD #lipid #lipidology #cardiovasculardisease #dyslipidemia #MedSky @nationallipid @Lipidjournal @Foundationofnla @erinmichos.bsky.social

011

Erin Michos, MD @erinmichos.bsky.social · 01/05/2025

Thank you for your support! ❤️

010

Reposted by Erin Michos, MD

Seme Burka @semeburka.bsky.social · 01/05/2025

Congratulations, Dr. Michos, on receiving such a well-deserved recognition! @erinmichos.bsky.social

162

Erin Michos, MD @erinmichos.bsky.social · 01/05/2025

Thank you! This is very meaningful to me. I am honored.

020

Reposted by Erin Michos, MD

Roger Blumenthal @rblument1.bsky.social · 01/05/2025

Congratulations to @erinmichos.bsky.social on being a recipient of the @hopkinsmedicine.bsky.social Susan M. MacDonald Sponsorship Award! @ciccaronecenter.bsky.social

2218

Reposted by Erin Michos, MD

American Journal of Preventive Cardiology @ajpcardio.bsky.social · 23/04/2025

New @aspcardio.bsky.social Clinical Practice Statement🫀: Framework to improve cardiometabolic care for South Asians—individual to population level. ow.ly/glCT50VGq9Y @pnatarajanmd.bsky.social @drmarthagulati.bsky.social #CardioSky #MedSky #SouthAsianHealth #HeartHealth #ASPC

078

Reposted by Erin Michos, MD

Meral KAYIKCIOGLU @meralkayikcioglu.bsky.social · 23/04/2025

Honored to speak at UKRAINE & EUROPE: UNITING HEARTS, organized by Ukrainian Atherosclerosis Society. I was deeply moved to join as an online speaker to support Ukrainian Colleagues during the most difficult circumstances. @eassociety.bsky.social @erinmichos.bsky.social

242